Skip to main content

Table 6 Validity testing (sensitivity, specificity, PPV and NPV with 95 % C.I) from the randomly selected headache sub-sample(a)

From: Prevalence of primary headache disorders in Fayoum Governorate, Egypt

Type of headache

Sensitivity (95 % CI)

Specificity (95 % CI)

PPV (95 % CI)

NPV (95 % CI)

Migraine

0.84 (0.68–1.00)

0.92 (0.85–0.99)

0.80 (0.62–0.98)

0.94 (0.87–1.00)

ETTH

0.85 (0.71–0.98)

0.93 (0.86–1.00)

0.88 (0.75–1.00)

0.91 (0.82–0.99)

CM

0.78 (0.51–1.00)

0.97 (0.92–1.00)

0.78 (0.51–1.00)

0.97 (0.92–1.00)

CTTH

0.91 (0.74–1.00)

0.97 (0.91–1.00)

0.83 (0.62–1.00)

0.98 (0.94–1.00)

Unclassified

0.40 (0.03–0.83)

0.97 (0.92–1.00)

0.50 (0.01–0.99)

0.95 (0.90–1.00)

  1. (a)Validity measures cannot be calculated for cluster headache because there were no cases of it in sub-sample results
  2. PPV positive predictive value, NPV negative predictive value